135 related articles for article (PubMed ID: 12123205)
21. Airway goblet cells and respiratory epithelial injury in an animal model of obliterative airways disease (OAD).
Dosanjh A; Wan B; Ikonen T; Boeke K; Morris RE
Am J Transplant; 2001 Nov; 1(4):321-4. PubMed ID: 12099375
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis of the Tracheal Epithelium Can Increase the Number of Recipient Bone Marrow-Derived Myofibroblasts in Allografts and Exacerbate Obliterative Bronchiolitis After Tracheal Transplantation in Mice.
Wang C; Xia T; Jiang K; Qiao X; Zhang X; Li J; Wang J; Nie J
Transplantation; 2016 Sep; 100(9):1880-8. PubMed ID: 27163540
[TBL] [Abstract][Full Text] [Related]
23. Obliterative airway disease progresses in heterotopic airway allografts without persistent alloimmune stimulus.
King MB; Pedtke AC; Levrey-Hadden HL; Hertz MI
Transplantation; 2002 Aug; 74(4):557-62. PubMed ID: 12352919
[TBL] [Abstract][Full Text] [Related]
24. Alcohol ingestion by donors amplifies experimental airway disease after heterotopic transplantation.
Mitchell PO; Guidot DM
Am J Respir Crit Care Med; 2007 Dec; 176(11):1161-8. PubMed ID: 17717204
[TBL] [Abstract][Full Text] [Related]
25. Hydrogen water alleviates obliterative airway disease in mice.
Ozeki N; Yamawaki-Ogata A; Narita Y; Mii S; Ushida K; Ito M; Hirano SI; Kurokawa R; Ohno K; Usui A
Gen Thorac Cardiovasc Surg; 2020 Feb; 68(2):158-163. PubMed ID: 31468277
[TBL] [Abstract][Full Text] [Related]
26. A novel MyD88 inhibitor attenuates allograft rejection after heterotopic tracheal transplantation in mice.
Yang M; Chen G; Zhang X; Ding Z; Miao Y; Yang Y; Chen ZK; Jiang F; Chang S; Zhou P
Transpl Immunol; 2019 Apr; 53():1-6. PubMed ID: 30472390
[TBL] [Abstract][Full Text] [Related]
27. T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas.
Kelly KE; Hertz MI; Mueller DL
Transplantation; 1998 Sep; 66(6):764-71. PubMed ID: 9771840
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor plays a major role in development of experimental obliterative bronchiolitis.
Krebs R; Hollmén ME; Tikkanen JM; Wu Y; Hicklin DJ; Koskinen PK; Lemström KB
Transplant Proc; 2006 Dec; 38(10):3266-7. PubMed ID: 17175244
[TBL] [Abstract][Full Text] [Related]
29. Anti-proliferative properties of the phosphodiesterase-4 inhibitor rolipram can supplement immunosuppressive effects of cyclosporine for treatment of obliterative bronchiolitis in heterotopic rat allografts.
Roth-Eichhorn S; Schade I; Kasper M; Ploetze K; Wunderlich J; Funk RH; Schueler S
J Heart Lung Transplant; 2001 Nov; 20(11):1188-98. PubMed ID: 11704479
[TBL] [Abstract][Full Text] [Related]
30. SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model.
Mesaki K; Yamane M; Sugimoto S; Fujisawa M; Yoshimura T; Kurosaki T; Otani S; Miyoshi S; Oto T; Matsukawa A; Toyooka S
Surg Today; 2019 May; 49(5):443-450. PubMed ID: 30617600
[TBL] [Abstract][Full Text] [Related]
31. The effect of basic fibroblast growth factor and omentopexy on revascularization and epithelial regeneration of heterotopic rat tracheal isografts.
Mayer E; Cardoso PF; Puskas JD; De Campos K; Oka T; Dardick I; Patterson GA
J Thorac Cardiovasc Surg; 1992 Jul; 104(1):180-8. PubMed ID: 1377312
[TBL] [Abstract][Full Text] [Related]
32. Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants.
Okazaki M; Gelman AE; Tietjens JR; Ibricevic A; Kornfeld CG; Huang HJ; Richardson SB; Lai J; Garbow JR; Patterson GA; Krupnick AS; Brody SL; Kreisel D
Am J Respir Cell Mol Biol; 2007 Dec; 37(6):625-30. PubMed ID: 17717320
[TBL] [Abstract][Full Text] [Related]
33. Growth factor upregulation during obliterative bronchiolitis in the mouse model.
Aris RM; Walsh S; Chalermskulrat W; Hathwar V; Neuringer IP
Am J Respir Crit Care Med; 2002 Aug; 166(3):417-22. PubMed ID: 12153981
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz BA; Mocarski E; Sandford G; Morris RE
J Heart Lung Transplant; 1998 May; 17(5):439-51. PubMed ID: 9628562
[TBL] [Abstract][Full Text] [Related]
35. The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft.
Suemitsu R; Yoshino I; Shoji F; Yamaguchi M; Tomita Y; Maehara Y
J Surg Res; 2004 Nov; 122(1):8-13. PubMed ID: 15522308
[TBL] [Abstract][Full Text] [Related]
36. Revascularization of the graft in obliterative bronchiolitis after heterotopic tracheal transplantation.
Nemska S; Daubeuf F; Frossard N
Physiol Rep; 2016 Feb; 4(4):. PubMed ID: 26908711
[TBL] [Abstract][Full Text] [Related]
37. Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells.
Higuchi T; Jaramillo A; Kaleem Z; Patterson GA; Mohanakumar T
Transplantation; 2002 Sep; 74(5):646-51. PubMed ID: 12352880
[TBL] [Abstract][Full Text] [Related]
38. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
Zhou H; Latham CW; Zander DS; Margolin SB; Visner GA
J Heart Lung Transplant; 2005 Oct; 24(10):1577-85. PubMed ID: 16210133
[TBL] [Abstract][Full Text] [Related]
39. Minimal dose of cyclosporin A for tracheal allografts.
Nakanishi R; Yasumoto K
Ann Thorac Surg; 1995 Sep; 60(3):635-9. PubMed ID: 7677491
[TBL] [Abstract][Full Text] [Related]
40. Recipient iNOS but not eNOS deficiency reduces luminal narrowing in tracheal allografts.
Minamoto K; Pinsky DJ
J Exp Med; 2002 Nov; 196(10):1321-33. PubMed ID: 12438423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
